Literature DB >> 2982842

N-(2-Aminoethyl)-5-isoquinolinesulfonamide, a newly synthesized protein kinase inhibitor, functions as a ligand in affinity chromatography. Purification of Ca2+-activated, phospholipid-dependent and other protein kinases.

M Inagaki, M Watanabe, H Hidaka.   

Abstract

We designed a simple procedure for the purification of Ca2+-activated, phospholipid-dependent protein kinase (protein kinase C) from rabbit brain, using affinity chromatography with a new affinity adsorbent. The adsorbent was synthesized by attaching the amino residue of N-(2-aminoethyl)-5-isoquinolinesulfonamide (H-9) to cyanogen bromide-activated Sepharose. H-9 is a potent competitive inhibitor of protein kinase C, cGMP-, and cAMP-dependent protein kinase with respect to ATP and exhibits inhibition constants of 18, 0.87, and 1.9 microM, respectively (Hidaka, H., Inagaki, M., Kawamoto, S., and Sasaki, Y. (1984) Biochemistry, 23, 5036). A 960-fold purification was achieved in the two-step procedure, which entailed DEAE-cellulose and the affinity chromatography. The resultant preparation was essentially homogeneous, as indicated by polyacrylamide gel electrophoresis under conditions of denaturation with sodium dodecyl sulfate. The affinity of protein kinase C for the H-9-Sepharose was high, and the enzyme could not be eluted either by a high concentration of sodium chloride or by 40% glycerol. The protein kinase C could be eluted from H-9-Sepharose by the buffer containing both 0.2 M NaCl and 20% glycerol, thereby suggesting that the binding between protein kinase C and H-9-Sepharose was due to both hydrophobic and electrostatic interactions. H-9 coupled to Sepharose retained both cyclic nucleotide-dependent protein kinases and protein kinase C, and these enzymes could be eluted separately by the buffer containing L-arginine, a potent inhibitor of these three kinases. The novel aspects of these three multifunctional protein kinases can thus be investigated using isoquinolinesulfonamide derivatives.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982842

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Molecular pharmacology of protein kinases.

Authors:  H Hidaka; M Hagiwara; T Chijiwa
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

2.  Protein kinase affinity reagents based on a 5-aminoindazole scaffold.

Authors:  Ratika Krishnamurty; Amanda M Brock; Dustin J Maly
Journal:  Bioorg Med Chem Lett       Date:  2010-10-21       Impact factor: 2.823

3.  Effects of phosphorylation of the neurofilament L protein on filamentous structures.

Authors:  S Hisanaga; Y Gonda; M Inagaki; A Ikai; N Hirokawa
Journal:  Cell Regul       Date:  1990-01

4.  Elevated intracellular Ca2+ acts through protein kinase C to regulate rabbit ileal NaCl absorption. Evidence for sequential control by Ca2+/calmodulin and protein kinase C.

Authors:  M Donowitz; M E Cohen; M Gould; G W Sharp
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

5.  Isozymic forms of rat brain Ca2+-activated and phospholipid-dependent protein kinase.

Authors:  K P Huang; H Nakabayashi; F L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

6.  Intracellular pH is increased after transformation of Chinese hamster embryo fibroblasts.

Authors:  S S Ober; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  NO donors inhibit Na,K-ATPase activity by a protein kinase G-dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye.

Authors:  Mohammad Shahidullah; Nicholas A Delamere
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

8.  Production and protein kinase C activation of diacylglycerols containing polymethylene-interrupted PUFA.

Authors:  Jun-ichi Morishige; Yoshimichi Takai; Kaoru Hirano; Tamotsu Tanaka; Kiyoshi Satouchi
Journal:  Lipids       Date:  2005-02       Impact factor: 1.880

9.  Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro.

Authors:  K A Qatsha; C Rudolph; D Marmé; C Schächtele; W S May
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

10.  Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.

Authors:  L Levesque; G Drapeau; J H Grose; F Rioux; F Marceau
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.